MG
ABBV icon

Mather Group’s AbbVie ABBV Stock Holding History

Mather Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.55M Sell
33,990
-645
-2% -$139K 0.07% 117
2026
Q1 		$7.53M Sell
34,635
-355
-1% -$78.7K 0.08% 99
2025
Q4 		$7.99M Buy
34,990
+102
+0.3% +$23.2K 0.08% 92
2025
Q3 		$8.08M Buy
34,888
+1,357
+4% +$276K 0.08% 91
2025
Q2 		$6.22M Buy
33,531
+3,153
+10% +$586K 0.07% 105
2025
Q1 		$6.36M Buy
30,378
+644
+2% +$125K 0.07% 102
2024
Q4 		$5.28M Buy
29,734
+950
+3% +$175K 0.07% 108
2024
Q3 		$5.68M Sell
28,784
-32,701
-53% -$6.1M 0.07% 107
2024
Q2 		$11.2M Buy
61,485
+34,287
+126% +$5.68M 0.14% 77
2024
Q1 		$4.21M Sell
27,198
-12,300
-31% -$2.12M 0.07% 104
2023
Q4 		$6.12M Buy
39,498
+1,787
+5% +$261K 0.1% 84
2023
Q3 		$5.62M Buy
37,711
+2,036
+6% +$299K 0.1% 81
2023
Q2 		$4.81M Buy
35,675
+857
+2% +$126K 0.08% 99
2023
Q1 		$5.55M Buy
34,818
+8,355
+32% +$1.28M 0.1% 82
2022
Q4 		$4.28M Sell
26,463
-298
-1% -$45.7K 0.08% 90
2022
Q3 		$3.59M Buy
26,761
+3,356
+14% +$482K 0.08% 91
2022
Q2 		$3.58M Buy
23,405
+410
+2% +$62.6K 0.08% 88
2022
Q1 		$3.73M Buy
+22,995
New +$3.34M 0.07% 83
2020
Q4 		– Sell
-18,206
Closed -$1.59M – 250
2020
Q3 		$1.59M Buy
18,206
+641
+4% +$60.3K 0.06% 68
2020
Q2 		$1.73M Buy
+17,565
New +$1.55M 0.08% 64

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Mather Group's ABBV Position: Q2 2026 in Review

Mather Group reduced its AbbVie (ABBV) stake by 1.9% in Q2 2026, selling an estimated $139K and leaving 33,990 shares worth $8.55M. The position accounts for 0.07% of the portfolio, ranked #117.

Mather Group first reported a position in ABBV in Q2 2020 and has held it in 20 quarters since. The position peaked at $11.2M in Q2 2024. 4,214 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Mather Group held 33,990 shares of AbbVie worth $8.55M as of Q2 2026.
  • Mather Group sold 645 AbbVie shares in Q2 2026, an estimated $139K.
  • AbbVie made up 0.07% of Mather Group's portfolio in Q2 2026, its #117 holding.
  • Mather Group first reported a position in AbbVie in Q2 2020 and has held it in 20 quarters since.
  • Mather Group's AbbVie position peaked at $11.2M in Q2 2024.
  • 4,214 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Mather Group's 13F filing for Q2 2026, filed 27 Jul 2026.